Literature DB >> 30895420

Structural identifiability and sensitivity.

Athanassios Iliadis1.   

Abstract

Ordinary differential equation models often contain a large number of parameters that must be determined from measurements by estimation procedure. For an estimation to be successful there must be a unique set of parameters that can have produced the measured data. This is not the case if a model is not structurally identifiable with the given set of inputs and outputs. The local identifiability of linear and nonlinear models was investigated by an approach based on the rank of the sensitivity matrix of model output with respect to parameters. Associated with multiple random drawn of parameters used as nominal values, the approach reinforces conclusions regarding the local identifiability of models. The numerical implementation for obtaining the sensitivity matrix without any approximation, the extension of the approach to multi-output context and the detection of unidentifiable parameters were also discussed. Based on elementary examples, we showed that (1°) addition of nonlinear elements switches an unidentifiable model to identifiable; (2°) in the presence of nonlinear elements in the model, structural and parametric identifiability are connected issues; and (3°) addition of outputs or/and new inputs improve identifiability conditions. Since the model is the basic tool to obtain information from a set of measurements, its identifiability must be systematically checked.

Entities:  

Keywords:  Ill-conditioning; Parametric identifiability; Rank of matrix; Sensitivity functions; Structural identifiability

Mesh:

Year:  2019        PMID: 30895420     DOI: 10.1007/s10928-019-09624-9

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  15 in total

1.  Structural identifiability of physiologically based pharmacokinetic models.

Authors:  James W T Yates
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-03-28       Impact factor: 2.745

2.  Controllability, observability and structural identifiability of multi input and multi output biological compartmental systems.

Authors:  C Cobelli; G Romanin-Jacur
Journal:  IEEE Trans Biomed Eng       Date:  1976-03       Impact factor: 4.538

Review 3.  Structural identifiability and indistinguishability of compartmental models.

Authors:  James W T Yates; R D Owen Jones; Mike Walker; S Y Amy Cheung
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-03       Impact factor: 4.481

4.  Approximations of the target-mediated drug disposition model and identifiability of model parameters.

Authors:  Leonid Gibiansky; Ekaterina Gibiansky; Tarundeep Kakkar; Peiming Ma
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-11-13       Impact factor: 2.745

Review 5.  Application of optimal design methodologies in clinical pharmacology experiments.

Authors:  Kayode Ogungbenro; Aristides Dokoumetzidis; Leon Aarons
Journal:  Pharm Stat       Date:  2009 Jul-Sep       Impact factor: 1.894

6.  Parameterisation affects identifiability of population models.

Authors:  Vittal Shivva; Julia Korell; Ian G Tucker; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-12-31       Impact factor: 2.745

7.  A review of techniques for parameter sensitivity analysis of environmental models.

Authors:  D M Hamby
Journal:  Environ Monit Assess       Date:  1994-09       Impact factor: 2.513

8.  The input-output relationship approach to structural identifiability analysis.

Authors:  Daniel J Bearup; Neil D Evans; Michael J Chappell
Journal:  Comput Methods Programs Biomed       Date:  2012-12-08       Impact factor: 5.428

9.  An approach for identifiability of population pharmacokinetic-pharmacodynamic models.

Authors:  V Shivva; J Korell; I G Tucker; S B Duffull
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-06-19

10.  Structural identifiability of systems biology models: a critical comparison of methods.

Authors:  Oana-Teodora Chis; Julio R Banga; Eva Balsa-Canto
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.